Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents
- Sponsor
- Shanghai Eye Disease Prevention and Treatment Center
- Study ID
- NCT07120737
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- High Myopia
- Myopia
Eligibility Criteria
- Sex
- ALL
- Age
- 7 Years - 14 Years
- Healthy Volunteers
- Not accepted
Interventions
- H.A.L.T. MAX spectacles — DEVICEThe Essilor® Stellest® 2.0 lens features a 2 times larger signal area, significantly enhancing the effect of slowing down myopia progression
Study Details
Children aged 7-14 years with high myopia were randomly assigned to a control group or an intervention group at a 1:1 ratio. The intervention group wore H.A.L.T. MAX lenses for at least 10 hours per day for 2 years, and the control group wore ordinary single-vision (SV) spectacles for at least 10 hours per day. At the 1-year follow-up examination (6-month visit), control subjects whose equivalent spherical diopter change (SER) was ≥0.75 D were switched to H.A.L.T. MAX lenses until the end of year 2. After entering year 2, all remaining control (SV) subjects will be replaced with H.A.L.T. MAX defofocus frames for at least 10 hours per day until the end of year 2. And continue to wear it for at least 10 hours per day. To evaluate the efficacy, safety and compliance of H.A.L.T. MAX lenses in delaying myopia progression in children with high myopia, and to provide a scientific basis for the formulation and practice of public health programs for delaying myopia progression and the risk of blindness and visual impairment caused by high myopia.
Key Dates
- First listed
- Aug 13, 2025
- Start date
- Sep 1, 2025
- Status verified
- Aug 2025
- Primary completion
- Mar 1, 2028
- Completion
- Dec 1, 2028
Study Design
- Enrollment
- 224 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: the intervention groupthe intervention group wore H.A.L.T. MAX for at least 10 hours a day for 2 years.
- No Intervention: The control groupThe control group will wear single vision lenses (SV) for at least 10 hours a day. In the first year (at 6-month follow-up), study participants in the control group with a spherical equivalent diopter change (SER) of ≥0.75 D will be switched to H.A.L.T. MAX lenses until the end of year 2. After entering year 2, all remaining control (SV) study participants will be replaced with H.A.L.T. MAX spectacles for at least 10 hours per day until the end of year 2.
Primary Outcome Measure
the proportion of change in SER of ≤ -0.75 (D) [ Time Frame: at the end of 1-year ]
Central Contacts
- Xiangui He021-62675806
Related Studies
- Diagnostic Innovations in Glaucoma StudyRecruiting · University of California, San Diego · La Jolla, California
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Contoura With Phorcides Compared to Wavefront Optimized LASIKRecruiting · Daniel Terveen · Bozeman, Montana
- Axial Length With Adult Onset Myopia (ALWAOM)Enrolling By Invitation · Art Optical Contact Lens, Inc. · St Louis, Missouri